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Abstract
Background: Adult outpatient parenteral antibiotic therapy (OPAT) programs have been reported in the literature for over
20 years, however there are no published reports quantifying preference for treatment location of patients referred to an OPAT
program. The purpose of this study was to elicit treatment location preferences and willingness to pay (WTP) from patients
referred to an OPAT program.
Methods: A multidisciplinary, single centre, prospective study at a 1000-bed Canadian adult tertiary care teaching hospital. This
study involved a WTP questionnaire that was administered over a 9-month study period. Eligible and consenting patients
referred to the OPAT program were asked to state their preference for treatment location and WTP for a hypothetical
treatment scenario involving intravenous antibiotic therapy. Multiple linear regression analysis was performed to determine
predictors of WTP.
Results: Of 131 eligible patients, 91 completed the WTP questionnaire. The majority of participants were males, married, in
their sixth decade of life and had a secondary school education or greater. The majority of participants were retired or they
were employed with annual household incomes less than $60,000. Osteomyelitis was the most common type of infection for
which parenteral therapy was required. Of those 87 patients who indicated a preference, 77 (89%) patients preferred treatment
at home, 10 (11%) patients preferred treatment in hospital. Seventy-one (82%) of these patients provided interpretable WTP
responses. Of these 71 patients, 64 preferred treatment at home with a median WTP of $490 CDN (mean $949, range $20 to
$6250) and 7 preferred treatment in the hospital with a median WTP of $500 CDN (mean $1123, range $10 to $3000). Tests
for differences in means and medians revealed no differences between WTP values between the treatment locations. The total
WTP for the seven patients who preferred hospital treatment was $7,859 versus $60,712 for the 64 patients who preferred
home treatment. Income and treatment location preference were independent predictors of WTP.
Conclusion: This study reveals that treatment at home is preferred by adult inpatients receiving intravenous antibiotic therapy
that are referred to our OPAT program. Income and treatment location appear to be independently associated with their
willingness to pay.
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Background
Adult outpatient parenteral antibiotic therapy (OPAT)
programs have been reported in the literature for over 20
years [1]. These programs have now become an accepted
alternative to inpatient therapy for select patients and
infection types [2-4]. OPAT programs have been demon-
strated to be a safe, effective and acceptable alternative to
hospitalization [5-7]. Cost analysis of OPAT programs in
the U.S., Canadian and other settings have been reported
[5,8-13].
An adult OPAT program was implemented at our hospital
in 1995. A cost analysis performed at our institution from
1995 to 1998 showed significant cost avoidance for both
the hospital and the Ministry of Health [14]. Informal
patient satisfaction surveys have shown that the program
has been well received by patients. However, there are no
published reports quantifying preference for treatment
location of OPAT program patients. Willingness to pay
(WTP) is a method of quantifying preference and this
methodology is gaining popularity in health care [15-19].
WTP provides a measure of how much an individual val-
ues a particular treatment preference.
The objective of this study was to elicit hypothetical infec-
tion treatment location preferences, and the willingness to
pay for this preferred treatment option from OPAT pro-
gram referral patients.
Methods
This was conducted as a multidisciplinary, single centre,
prospective study at a 1000-bed Canadian adult tertiary
care teaching hospital. Our OPAT program receives about
250 patient referrals and provides approximately 3,000
patient-days of outpatient parenteral therapy per year
[20]. General characteristics of patients managed by this
service are described elsewhere [14,20]. Adult patients are
accepted into the program if they had a proven or sus-
pected infection requiring one or more parenteral antimi-
crobials for an expected minimum duration of 5 days, are
medically stable, have an acceptable venous access, dem-
onstrate a willingness and capability to perform the neces-
sary self-management tasks and live in a suitable home
environment with access to a telephone. Once enrolled,
the OPAT pharmacist and nurses provide patient teaching,
insert the appropriate vascular device, liaise with commu-
nity nursing personnel, coordinate delivery of drugs and
supplies and arranged appropriate patient follow up.
These patients are treated in their home environment and
return to the hospital periodically for follow-up purposes
only. Patients requiring short courses of parenteral antibi-
otics are typically excluded from the program and are
treated as inpatients or managed in a hospital medical
daycare setting.
This study was approved by the University Ethics Com-
mittee and the Hospital Research Committee.
Patient enrollment
Patients referred to the OPAT program during the 9-
month study (September 1999 – June 2000) were consid-
ered eligible for the patient preference assessment. For
inclusion into the study, the questionnaire had to be
administered to the patient prior to assessment by the
OPAT clinical staff for possible inclusion into the pro-
gram. Only consenting patients were administered the
WTP questionnaire. This precaution was taken to avoid
the possibility of biased responses from the participants in
an attempt to obtain the treatment location of their
choice.
Willingness to pay
Contingent valuation methodology (CVM) was used to
quantitatively measure patient preference (i.e. WTP) for
intravenous antibiotic treatment location [15-19]. CVM is
a survey-based approach for eliciting a consumer's mone-
tary valuations for program benefits for use in cost-benefit
analysis. The specific methodology employed was similar
to that adopted by Donaldson et al [21]. The consumer
utility being measured was compensating variation and
the survey measured WTP in the context of program avail-
ability. Since the questionnaires were given to individuals
undertaking the valuation who were already consumers of
the treatment in question (i.e. were receiving parenteral
antimicrobials when enrolled) and thus the primary
uncertainty at the time of the questionnaire was the prob-
ability of treatment course outcomes, an ex-post perspec-
tive was adopted [15,16].
The WTP questionnaire consisted of two hypothetical sce-
narios that were created based upon OPAT program data
collected during the period 1995–1998 (see Additional
File 1) [14]. Each hypothetical scenario involved an infec-
tion that required a 23-day course of intravenous antibiot-
ics (the average duration of therapy for patients enrolled
in the OPAT program). The first scenario described a hos-
pital treatment course, while the second scenario
described a similar treatment regimen that was adminis-
tered in the home setting. Using these historic data, the
risks associated with each treatment location were also
provided to the patient [14]. Patients were asked to specify
their preference for treatment location based upon these
scenarios. Utilizing open-ended questions, patients were
asked to quantify their preference by stating how much
they would be willing to pay to obtain treatment in their
preferred location.
The survey was initially designed and tested on ten
patients, four clinical nurse specialists and two infectious
diseases specialists. We utilized comments from theseBMC Health Services Research 2005, 5:43 http://www.biomedcentral.com/1472-6963/5/43
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individuals to modify our survey in order to improved
readability and understandability.
Data collection
A single investigator coordinated all patient self-adminis-
tered WTP questionnaires. Partial completion of the sur-
veys was identified in four of the first eleven patients;
thereafter, the investigator examined the questionnaires
for completeness at bedside and encouraged patients to
provide responses if necessary. If requested by the patient,
the questionnaire was read aloud and the investigator
recorded the patient's responses. In these cases, the com-
pleted questionnaire was subsequently reviewed with the
patient to ensure accuracy. Demographic information,
socioeconomic data, infection details and WTP for treat-
ment location were collected for all patients.
Data analysis
Means, medians and ranges for WTP by treatment prefer-
ence location were determined. Differences in means and
medians were testing using t-tests and Mann-Whitney U
tests, respectively. To estimate an overall monetary valua-
tion, a total WTP was calculated for patients preferring
hospital treatment and a total WTP was also calculated for
those preferring home treatment.
A positive association between WTP and income was
assessed to determine the construct validity of our ques-
tionnaire [22]. WTP was examined for normality using
histograms to determine if a natural log transformation
was necessary to fit the assumptions of linear regression.
Using WTP as the dependent variable, multiple linear
regression was utilized. Univariate analyses were per-
formed between each of the possible predictor variables
(gender, marital status, level of education, employment,
annual household income, infection type) and the
dependent variable using ordinary least-squares linear
regression.
Variables associated with WTP with a p-value < = 0.10 in
the univariate analyses were considered in the multiple
linear regression models. Adjusted r2 was calculated for
the multivariable models to determine the amount of var-
iance in the outcome variable explained by the predictor
variables in the final models. Among significant variables,
two-way interactions were investigated. No adjustments
were made to p-values to account for multiple compari-
sons. Studentized residuals and Cook's distance were
examined to determine if assumptions of multiple linear
regression were violated. Two-sided P values are reported
for all analyses. A p value of less than 0.05 was considered
to be statistically significant. All analyses were conducted
by using SPSS, version 10.
Results
During the 9-month study period, 131 patients were con-
sidered eligible for enrollment in the contingent valuation
analysis. Of these patients, 40 were excluded, as the inves-
tigator was unavailable to conduct an interview prior to
the assessment by the OPAT team, informed consent
could not be obtained due to language barriers, decreased
cognitive status was evident or patients simply declined to
participate. The remaining 91 patients completed the WTP
questionnaire.
Patient demographics and socioeconomic status are
reported in Table 1. Participants were typically married
males in their sixth decade of life with a secondary school
education or greater. The majority of participants were
retired or were employed with an annual household
Table 1: Patient demographics
Parameter Value
No. of Patients 91
Mean age, years (range) 56 (25–81)
Gender
Male (%) 63 (69)
Marital Status (%)
Married 60 (66)
Divorced 11 (12)
Widowed 9 (10)
Single 10 (12)
Highest Level of Education (%)
Elementary School 7 (8)
Secondary School 29 (32)
Trades/Technical College 34 (36)
University Degree 16 (18)
Post-graduate 5 (6)
Employment (%)
Retired 45 (49)
Employed 29 (32)
Unemployed 16 (18)
Unknown 1 (1)
Annual Household Income (%)
< $20,000 22 (24)
$20,000–39,999 20 (23)
$40,000–59,999 22 (24)
$60,000–79,999 9 (10)
$80,000–99,999 3 (3)
$100,000–149,000 7 (8)
> $150,000 4 (4)
Unknown 4 (4)
Type of Infection (%)
Osteomyelitis 39 (43)
Infected pacemaker/wires 9 (10)
Endocarditis 9 (10)
Wound infection 7 (8)
Abscess 6 (7)
Bacteremia 4 (5)
Other1 17 (17)
1Meningitis (3), pneumonia (4), infected graft of lower limb (2), line 
sepsis (2), septic arthritis (2), cellulites (1), pyelonephritis (1), CMV 
(1), discitis (1)BMC Health Services Research 2005, 5:43 http://www.biomedcentral.com/1472-6963/5/43
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income of less than $60,000. Osteomyelitis was the most
common type of infection for which parenteral therapy
was required.
Willingness to pay
Of the 91 patients who were enrolled in the study, 87
(96%) indicated a treatment location preference while the
remaining four participants had no preference. Of those
87 patients who indicated a preference, 77 (89%) pre-
ferred treatment at home while 10 (11%) preferred treat-
ment in hospital. Seventy-one (82%) patients provided an
interpretable response regarding WTP for treatment in
their preferred location. Of those 16 patients (13 patients
with a preference for home therapy vs. 3 patient with a
preference for hospital therapy) who did not provide an
interpretable response, one registered an astronomically
high "protest" WTP far exceeding their ability to pay,
while 15 indicated a treatment preference but provided no
monetary value.
For those 71 patients who provided an interpretable
response, 64 patients preferred treatment at home with a
median WTP of $490 CDN (mean $949, range $20 to
$6250), and 7 patients preferred treatment in the hospital
with a median WTP of $500 CDN (mean $1123, range
$10 to $3000). Tests for differences in means and medi-
ans revealed no statistically significant differences
between WTP values between the treatment locations at
the 5% level. The total WTP for the seven patients who
preferred hospital treatment was $7,859 versus $60,712
for the 64 patients who preferred home treatment.
The natural logarithm of WTP values approximated a nor-
mal distribution, thus satisfying this assumption of linear
regression (Figure 1). Only seventy-five patients (71
patients with an interpretable response plus those 4
patients with no treatment location preference) were
included in the regression analysis. Multiple linear regres-
sion analysis revealed that income and treatment location
preference were independent predictors of WTP (Table 2).
There was a trend towards respondents with lower
incomes being willing to pay slightly less for their pre-
ferred treatment location than those with the highest
incomes (p = 0.067). In addition, people who stated pref-
erences were willing to pay significantly more for than
those who did not state a preference (p < 0.001). In the
multiple linear regression model that included interaction
terms (adjusted r2 = 0.543), there was also a significant
interaction between income and treatment location pref-
erence such that patients with the lowest income were
willing to pay significantly more for hospital treatment
than for home treatment (p < <0.0001). The fact that there
was a significant association between WTP and ability to
pay (i.e. higher income) validates the theoretical construct
of our survey.
Discussion
To our knowledge, this is the first published report quan-
tifying preference for treatment location in an adult OPAT
program patients using WTP.
According to our WTP analysis, candidates for the pro-
gram expressed an overwhelming preference for treatment
in the home setting. Our results also demonstrated that
the WTP values were similar between those patients who
preferred to be treated at home and those who wished to
remain in hospital. Accordingly, the total WTP value was
greater (in fact, almost 8-fold greater) for those patients
preferring treatment at home. This reflects the overall
magnitude of societal preference for the management of
infectious diseases that require intravenous therapy, but
does not require institutionalization.
There were several limitations to this study. We conducted
this trial in one adult acute care institution, thus caution
must be exercised when attempting to generalize the
results to other health care settings involving different
patient populations, and other infectious diseases which
will require different treatment regimens. We relied on a
hypothetical treatment scenario in our attempt to solicit a
preference location and willingness to pay for this patient
population. As the scenario did not necessarily reflect the
treatment that they were about to receive, we must be
careful in our extrapolation of the results. Although we
acknowledge the potential problems with using such sce-
narios in CVM, we believe that this effect was minimized
by surveying patients who were currently experiencing an
infection that initiated a consult from the OPAT team (i.e.
Figure 1BMC Health Services Research 2005, 5:43 http://www.biomedcentral.com/1472-6963/5/43
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the ex-post perspective). We believe that most of these
individuals would be able to realistically comprehend the
health outcomes described in our scenarios.
We also relied on open-ended technique rather than a bid-
ding-game technique to solicit a WTP value. While the
bidding game technique forces an upper and lower limit
to the patient response and can be criticized for introduc-
ing a starting point bias, the open-ended technique has
also been questioned. As described by O'Brien and Vira-
montes, patient naivety regarding health care costs due to
the Canadian universal health insurance environment
may lead to an inability to quantify the value of an
expected health improvement [16]. The broad range of
WTP values provided by our participants may be a reflec-
tion of this naivety. In addition, O'Brien and Gafni discuss
that open-ended questions often elicit large numbers of
non-responses or protest zero responses [21]. Indeed,
some patients in our study expressed difficulty in placing
a dollar value on their choice of treatment location. In
some cases, this appeared to be a protest against the inter-
view question and reflected a concern that their response
would be used to determine a future fee for their treat-
ment preference. In other cases, this may have been
related to the fact that patients are not typically aware of,
nor directly pay for, the costs of health care services in the
Canadian health care system. Finally, WTP surveys meas-
ure only what a patient claims they are willing to pay for
a particular treatment. The magnitude of payment is not
necessarily an accurate reflection of what they would actu-
ally be willing to pay if they were to encounter the actual
scenario.
As expected, ability to pay was associated with WTP and
this functioned as a confirmation of construct validity of
our questionnaire. Unfortunately, as mentioned by
Drummond et al, there is not an actual market for most
health programs and, thus, there is no "gold standard"
against which one can compare WTP values [22]. It is,
therefore, difficult to establish criterion validity in this
context.
Conclusion
This study reveals that the majority, but not all, of adult
inpatients receiving parenteral antibiotic therapy who are
referred to an outpatient parenteral antibiotic therapy
program prefer to be treated at home. Income and treat-
ment location appear to independently predict their will-
ingness to pay.
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